Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/556
Title: Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer
Authors: Menjón-Beltrán, S
Olivencia-Dueso, R
González-Jiménez, E
Titos, MJ
metadata.dc.contributor.authoraffiliation: [Menjón-Beltrán,S; Olivencia-Dueso,R; González-Jiménez,E; Titos,MJ] Unidad de Ginecología Oncológica, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Keywords: Anticuerpos Monoclonales Humanizados;Antineoplásicos;Neoplasias de la Mama;Metástasis de la Neoplasia;Antimetabolitos Antineoplásicos;Femenino;Humanos;Receptor erbB-2
metadata.dc.subject.mesh: Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents
Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms
Medical Subject Headings::Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasis
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Antimetabolites, Antineoplastic
Medical Subject Headings::Check Tags::Female
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptor, erbB-2
Issue Date: 19-Jun-2007
Publisher: BioMed Central
Citation: Menjón-Beltrán S, Olivencia-Dueso R, González-Jiménez E, Titos MJ .Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer. Breast Cancer Research 2007, 9(Suppl 1):P11
Abstract: Trastuzumab and gemcitabine are two active drugs for meta-static breast cancer (MBC) treatment. We conducted a retrospective study of this combination in patients with Her2+ MBC in our hospital.
Description: Poster Presentation. This article is part of the supplement: VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer.
URI: http://hdl.handle.net/10668/556
metadata.dc.relation.publisherversion: http://breast-cancer-research.com/content/9/S1/P11
metadata.dc.identifier.doi: 10.1186/bcr1717
ISSN: 1465-5411 (Print)
1465-542X (Online)
Appears in Collections:01- Artículos - Hospital Virgen de las Nieves

Files in This Item:
File Description SizeFormat 
Menjon_StudyOfThe.pdfPoster presentation45,41 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons